Launch of 3rd commercial probiotic strain: healthy skin

1
Passport - World Market for Beauty and Personal Care, September 2020: Euromonitor International
2

Global Skin Microbiome Modulators Market: Focus on Products, Applications, Distribution Channels, Country Data (14
Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030: Research and Markets





23 March 2021

Launch of 3
rd
commercial probiotic strain: to promote healthy skin
Blis Technologies Limited’s (BLT:NZX) latest commercial patented probiotic strain BLIS Q24™ is the key
active ingredient in a new product line for the probiotic pioneers: cosmetic skincare.
The product will be launched under a new brand “Unconditional Skincare Co.” and will be available
exclusively online at www.unconditionalskin.com. One product will be launched initially: Live
Probiotic Hydration Serum powered by BLIS Q24™. Further cosmetic skincare products for the face
are in development and the company is also considering a range of further potential applications
including body and personal care.
The product is scientifically proven to promote skin health. In addition to significant clinical research,
consumer market research has been undertaken in both NZ and the USA with ~130 consumers
completing 30 days usage of the product during 2020/2021. Results were positive; the concept was
highly engaging, and the product delivered. Key highlights included participants indicating a reduction
in acne (~80%), less dryness (~82%) and a reduction in redness (~62%). Overall, 72% of participants
indicated that the product was better than their regular moisturiser.
Blis has developed a breakthrough formulation (patent pending) that uniquely allows BLIS Q24™ to
stay alive and have a long shelf-life (up to 2 years). This is viewed as a significant step forwards in the
skincare industry. There has been a steady increase in the number of cosmetic skincare brands
claiming probiotic properties, but most have been unable to produce a product that includes a true
probiotic; that is live bacteria. Those that have, tend to have short shelf-life. Most products claiming
to be “Probiotic” are using dead cultures, prebiotics (compounds that feed probiotics but are not
probiotics themselves) or postbiotics (by-products of live bacteria or lysates).
BLIS Q24™ works with a range of skin types to re-balance the skin’s microbiome, enhancing the natural
qualities of skin. The probiotic strain works by inhibiting the growth of bad bacteria on the skin,
therefore increasing prevalence of good bacteria. This provides the skin with the ability to fight off
frequent issues including redness, blemishes, dryness and oiliness.
Probiotic skincare is predicted to be a key trend in 2021 as the skin microbiome becomes a consumer
focus. Consumer interest in more natural and sustainable products is leading to a move away from
big mass players and an openness to small, authentic and innovative brands. This provides an
opportunity for Blis with its new breakthrough, innovative product: Live Probiotic Hydration Serum
powered by BLIS Q24™.
The global premium skincare market was valued at US$140 billion in 2019
1
. eCommerce is a big driver
in the beauty and personal care category and is set to register a higher forecast compound annual
growth rate (CAGR) than any other channel globally, at 11% over 2019-2024
1
. In addition, Covid-19
had a significant impact on buying patterns in the category and it is expected consumers will continue
to shop online for skincare products.

Blis Technologies Limited: 81 Glasgow Street, South Dunedin 9012, PO Box 2208, Dunedin 9012, New Zealand
T:+64 3 474 0988 E: info@blis.co.nz W: www.blis.co.nz
The relatively new global “microbiome modulators” skincare market was valued at US$541 million in
2019 (of which the probiotic segment contributes roughly 68%) and is anticipated to grow to US$2.97
billion by 2030. This is aided by the strong consumer trend towards the health of the microbiome
(inside and out) and the search for natural ingredient-based products in the skincare category
2
. Strong
growth is seen in both prebiotics and probiotics, with consumers looking for scientifically proven,
active ingredients that can deliver results. Further evidence of the trend towards probiotic skincare
investment is evident in the increased M&A activity in innovative small-sized businesses or start-ups:
including Unilever Ventures acquiring shareholding in Gallinee (2018) and H&H Group acquiring
Aurelia (2019).
Ends

For further information, please contact:

Brian Watson
CEO
+64 27 705 9133


About Blis Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics
Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation
with evidence-based research and the highest quality production controls enables the delivery of probiotic
solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and
gum health and skin health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and
the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.


Website: www.unconditionalskin.com
Instagram: @unconditionalskin #BLISQ24 #USC
Facebook: @unconditionalskin